Clinical Trial: Lumateperone Added to Antidepressant Therapy in Adults With Major Depressive Disorder Experiencing Emotional Blunting

U.S., Sept. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07824206) titled 'Lumateperone Added to Antidepressant Therapy in Adults With Major Depressive Disorder Experiencing Emotional Blunting' on Sept. 11.

Brief Summary: The purpose of this study is to evaluate whether or not adding lumateparone to current antidepressant treatment in adults with major depressive disorder experiencing blunted emotion will reduce or eliminate the blunted emotion as rated by the Oxford Depression Questionnaire.

Study Start Date: Sept., 2026

Study Type: INTERVENTIONAL

Condition: Blunted Emotion in Major Depressive Disorder

Intervention: DRUG: lumateparone 42 mg once daily

lumateparone 42 mg once daily added to current...